Inhibikase Therapeutics (IKT) Earnings
|
Expand Research on IKT
| Next EPS Date | 11/16/26 | EPS Growth Rate | +15.4% |
|---|---|---|---|
| Average EPS % Beat Rate | 0.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/16/26  |
Q326 | N/A | -$0.11 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/11/26 |
Q226 | -$0.11 | -$0.11 | $0.00 | N/A | N/A | N/A |  | | Details | |
| 5/12/26 | Q126 | -$0.10 | $0.00 | -$0.10 | N/A | N/A | N/A | | | Details | |
| 11/14/25 | Q325 | -$0.13 | $0.00 | -$0.13 | N/A | N/A | N/A | | | Details | |
| 8/15/25 | Q225 | -$0.11 | $0.00 | -$0.11 | N/A | N/A | N/A | | | Details | |
| 8/14/25 |
Q225 | N/A | -$0.12 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/15/25 | Q125 | -$0.15 | $0.00 | -$0.15 | N/A | N/A | N/A | | | Details | |
| 11/14/24 | Q324 | -$0.65 | $0.00 | -$0.65 | N/A | N/A | N/A | | | Details |
